Conexeu Sciences Inc. (CNXU)
Conexeu Sciences will go public soon, but the exact IPO date is still unknown.
IPO Price
$10.00
Shares Offered
9,481,123
Deal Size
$94.81M
Chart not available yet
Data will show when the stock starts trading.
| Market Cap | 198.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.92M |
| Shares Out | 19.85M |
| EPS (ttm) | -0.20 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CNXU
Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property developed over more than a decade at the University of British Columbia and the BC Professional Firefighters Burn and Wound Healing Laboratory. The Company's only device candidate is the CXU™ scaffold device candidate. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound c... [Read more]
Industry Medical Devices
Sector Healthcare
Founded 2022
Country United States
Stock Exchange NASDAQ
Ticker Symbol CNXU
Website https://conexeu.com/
Financial Performance
Financial StatementsNews
Conexeu Sciences IPO Registration Document (S-1)
Conexeu Sciences has filed to go public with an IPO on the NASDAQ
25 days ago - SEC